TC BioPharm Ltd
NASDAQ:TCBP
Balance Sheet
Balance Sheet Decomposition
TC BioPharm Ltd
TC BioPharm Ltd
Balance Sheet
TC BioPharm Ltd
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1
|
1
|
2
|
5
|
2
|
|
| Cash Equivalents |
1
|
1
|
2
|
5
|
2
|
|
| Total Receivables |
3
|
1
|
1
|
2
|
1
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
2
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
2
|
|
| Total Current Assets |
4
|
2
|
4
|
7
|
6
|
|
| PP&E Net |
6
|
5
|
4
|
3
|
3
|
|
| PP&E Gross |
6
|
5
|
4
|
3
|
3
|
|
| Accumulated Depreciation |
1
|
2
|
3
|
4
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
1
|
|
| Total Assets |
10
N/A
|
7
-28%
|
8
+10%
|
11
+37%
|
9
-18%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
0
|
1
|
2
|
1
|
3
|
|
| Short-Term Debt |
0
|
0
|
14
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
|
| Other Current Liabilities |
2
|
2
|
2
|
6
|
0
|
|
| Total Current Liabilities |
4
|
4
|
21
|
9
|
5
|
|
| Long-Term Debt |
3
|
3
|
2
|
2
|
0
|
|
| Other Liabilities |
6
|
4
|
2
|
0
|
1
|
|
| Total Liabilities |
13
N/A
|
11
-16%
|
25
+132%
|
11
-55%
|
6
-43%
|
|
| Equity | ||||||
| Common Stock |
2
|
2
|
0
|
0
|
0
|
|
| Retained Earnings |
15
|
20
|
17
|
17
|
39
|
|
| Additional Paid In Capital |
11
|
15
|
33
|
17
|
41
|
|
| Total Equity |
3
N/A
|
3
-32%
|
17
-394%
|
0
+100%
|
3
N/A
|
|
| Total Liabilities & Equity |
10
N/A
|
7
-28%
|
8
+10%
|
11
+37%
|
9
-18%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
28
|
28
|
28
|
2
|
21
|
|